Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

MicroRNA biomarkers in leprosy: insights from the Northern Brazilian Amazon population and their implications in disease immune-physiopathology

Cáceres-Durán MÁ, Pinto P, Magalhães L, et al. Frontiers Media SA. Frontiers in Genetics. 2024;
Download PDF
Publication

Global Consultation for updating operational plans for island countries and countries close to elimination of leprosy: towards implementation of the Global Leprosy Strategy 2021–2030

World Health Organization . 2024;
Download PDF
Publication

Persons affected by leprosy (Hansen’s disease) must have access to the highest attainable standard of support and care: UN experts

United Nations Human Rights - Office of the High Commissioner . 2024;
Download PDF
Publication

A Comparison of Cathelicidin Levels in the Skin of Leprosy Patients and Their Household Contacts

Argentina F, Suwarsa O, Gunawan H, et al. Academy of Sciences and Arts of Bosnia and Herzegovina. Acta Medica Academica. 2023;
Download PDF
Publication

Risk Factors for Leprosy in All Health Centers at the Bau-Bau City

Sriningsih C, Sunarsih S, Rahmawati R. Lembaga Penelitian dan Pengabdian Masyarakat Universitas Mandala Waluya. Waluya The International Science of Health Journal. 2023; 2 (4) : 172-175.
Download PDF
Publication

Características clínico epidemiológicas de pacientes con Lepra en un centro de referencia

Ortiz N, Benitez J, Acosta ME. Instituto de Investigaciones en Ciencias de la Salud. Revista del Instituto de Medicina Tropical. 2023; 18 (2) : 11-18.
Download PDF
Publication

Tendência das taxas de detecção da hanseníase em um estado da Região Norte do Brasil

Neves DCDO, Silva ARD, Xavier MB, et al. Instituto Evandro Chagas. Revista Pan-Amazônica de Saúde. 2023;
Download PDF
Publication

Stigmatisierung beenden und Würde anerkennen: Von Herausforderungen und Hoffnungen zum Welt-Lepra-Tag 2024

Fastenau A, Friedl C, Kasang C. Epidemiologisches Bulletin. 2024;
Download PDF
Publication

Molecular epidemiological characteristics of Mycobacterium leprae in highly endemic areas of China during the COVID-19 epidemic

Zhou J, Wu Z, Tong Y, et al. Frontiers Media SA. Frontiers in Public Health. 2024;
Download PDF
Publication

Bacilloscopy for leprosy in Brazil's public health system between 2013 and 2022

Barbosa-Lima R, Vivian GF, Alba LMR, et al. Revista Ciencias em Saude. REVISTA CIÊNCIAS EM SAÚDE. 2023; 13 (4) : 38-45.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 105
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD